Skip to main content
    • Aa
    • Aa

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings

  • J. H. Meijer (a1), N. Dekker (a1), M. W. Koeter (a2), P. J. Quee (a3), N. J. M. van Beveren (a4) and C. J. Meijer (a1)...

The relationship between cannabis use and cognitive functioning in patients with psychosis has yielded contradictory findings. In individuals at genetic high risk for psychosis, information is sparse. The aim of this study was to assess the association between recency and frequency of cannabis use and cognitive functioning in patients with psychosis and their unaffected siblings.


We conducted a cross-sectional study in 956 patients with non-affective psychosis, 953 unaffected siblings, and 554 control subjects. Participants completed a cognitive test battery including assessments of verbal learning, set shifting, sustained attention, processing speed, working memory, acquired knowledge, reasoning and problem solving and social cognition. Cannabis use was assessed by urinalysis and by the Composite International Diagnostic Interview. Using random-effect regression models the main effects of cannabis (recency and frequency) and the interaction with status (patient, sibling, control) on cognitive functioning were assessed.


Current cannabis use was associated with poorer performance on immediate verbal learning, processing speed and working memory (Cohen's d −0.20 to −0.33, p<0.005). Lifetime cannabis use was associated with better performance on acquired knowledge, facial affect recognition and face identity recognition (Cohen's d+0.17 to +0.33, p<0.005). There was no significant interaction between cannabis and status on cognitive functioning.


Lifetime cannabis-using individuals might constitute a subgroup with a higher cognitive potential. The residual effects of cannabis may impair short-term memory and processing speed.

Corresponding author
*Address for correspondence: L. de Haan (GROUP Investigator), AMC-Academisch Psychiatrisch Centrum, Postbus 75867, 1070 AW Amsterdam, The Netherlands. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

NC Andreasen , M Flaum , S Arndt (1992). The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.

TR Barnes , SH Mutsatsa , SB Hutton , HC Watt , EM Joyce (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188, 237242.

G Bersani , V Orlandi , GD Kotzalidis , P Pancheri (2002). Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience 252, 8692.

N Brand , J Jolles (1985). Learning and retrieval rate of words presented auditorily and visually. Journal of General Psychology 112, 201210.

A Caspi , TE Moffitt , M Cannon , J McClay , R Murray , H Harrington , A Taylor , L Arseneault , B Williams , A Braithwaite , R Poulton , IW Craig (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 57, 11171127.

M Cohen , N Solowij , V Carr (2008). Cannabis, cannabinoids and schizophrenia: integration of the evidence. Australian and New Zealand Journal of Psychiatry 42, 357368.

CM Coulston , M Perdices , CC Tennant (2007 a). The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophrenia Research 96, 169184.

CM Coulston , M Perdices , CC Tennant (2007 b). The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues. Australian and New Zealand Journal of Psychiatry 41, 869884.

DC D'Souza , WM Abi-Saab , S Madonick , K Forselius-Bielen , A Doersch , G Braley , R Gueorguieva , TB Cooper , JH Krystal (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry 57, 594608.

E de la Serna , I Baeza , J Toro , S Andres , O Puig , V Sanchez-Guistau , S Romero , M Bernardo , J Castro-Fornieles (2010). Relationship between clinical and neuropsychological characteristics in child and adolescent first degree relatives of subjects with schizophrenia. Schizophrenia Research 116, 159167.

P DeRosse , A Kaplan , KE Burdick , T Lencz , AK Malhotra (2010). Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophrenia Research 120, 95–100.

H Ehrenreich , T Rinn , HJ Kunert , MR Moeller , W Poser , L Schilling , G Gigerenzer , MR Hoehe (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berlin) 142, 295301.

DM Fergusson , JM Boden (2008). Cannabis use and later life outcomes. Addiction 103, 969976.

MJ Fernandez-Serrano , M Perez-Garcia , A Verdejo-Garcia (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews 35, 377406.

PA Fried , B Watkinson , R Gray (2005). Neurocognitive consequences of marihuana – a comparison with pre-drug performance. Neurotoxicology and Teratology 27, 231239.

Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2011). Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient–sibling and sibling–control pairs. Archives of General Psychiatry 68, 138147.

A González-Pinto , S Alberich , S Barbeito , M Gutierrez , P Vega , B Ibáñez , MK Haidar , E Vieta , C Arango (2011). Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophrenia Bulletin 37, 631639.

JA Hanley , A Negassa , MD Edwardes , JE Forrester (2003). Statistical analysis of correlated data using generalized estimating equations: an orientation. American Journal of Epidemiology 157, 364375.

C Henquet , A Rosa , L Krabbendam , S Papiol , L Fananás , M Drukker , JG Ramaekers , J van Os (2006). An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31, 27482757.

AB Ilan , ME Smith , A Gevins (2004). Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berlin) 176, 214222.

MC Jockers-Scherubl , T Wolf , N Radzei , P Schlattmann , J Rentzsch , de CA Gomez-Carrillo , KP Kuhl (2007). Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 10541063.

CC Joyal , P Halle , D Lapierre , S Hodgins (2003). Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophrenia Research 63, 297299.

SR Kay , A Fiszbein , LA Opler (1987). The Positive And Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261276.

DH Linszen , PM Dingemans , ME Lenior (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273279.

EM Loberg , K Hugdahl (2009). Cannabis use and cognition in schizophrenia. Frontiers in Human Neuroscience. Published online: 24 November 2009. doi: 10.3389/neuro.09.053.2009.

M Lynskey , W Hall (2000). The effects of adolescent cannabis use on educational attainment: a review. Addiction 95, 16211630.

KT Mueser , RE Drake , MA Wallach (1998). Dual diagnosis: a review of etiological theories. Addictive Behaviors 23, 717734.

KA Nolan , RM Bilder , HM Lachman , J Volavka (2004). Catechol O-methyltransferase val158met polymorphism in schizophrenia: differential effects of val and met alleles on cognitive stability and flexibility. American Journal of Psychiatry 161, 359361.

KHR Nuechterlein , ME Dawson (1984). Information processing and attentional functioning in the developmental course of schizophrenics disorders. Schizophrenia Bulletin 10, 160203.

BW Palmer , SE Dawes , RK Heaton (2009). What do we know about neuropsychological aspects of schizophrenia? Neuropsychology Review 19, 365384.

A Perkonigg , RD Goodwin , A Fiedler (2008). The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction 103, 439449.

RG Pertwee (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology 153, 199215.

HG Pope Jr., AJ Gruber , JI Hudson , MA Huestis , D Yurgelun-Todd (2002). Cognitive measures in long-term cannabis users. Journal of Clinical Pharmacology 42, 41S47S.

S Potvin , C Briand , A Prouteau , RH Bouchard , O Lipp , P Lalonde , L Nicole , A Lesage , E Stip (2005). CANTAB explicit memory is less impaired in addicted schizophrenia patients. Brain and Cognition 59, 3842.

S Potvin , CC Joyal , J Pelletier , E Stip (2008). Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis. Schizophrenia Research 100, 242251.

JG Ramaekers , G Kauert , EL Theunissen , SW Toennes , MR Moeller (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology 23, 266277.

JM Rodriguez-Sanchez , R Ayesa-Arriola , I Mata , T Moreno-Calle , R Perez-Iglesias , C Gonzalez-Blanch , JA Perianez , JL Vazquez-Barquero , B Crespo-Facorro (2010). Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophrenia Research 124, 142151.

M Ruiz-Veguilla , M Gurpegui , ML Barrigon , M Ferrin , E Marin , JL Rubio , B Gutierrez , A Pintor , J Cervilla (2009). Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use. Schizophrenia Research 107, 158164.

T Schnell , D Koethe , J Daumann , E Gouzoulis-Mayfrank (2009). The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berlin) 205, 4552.

S Sevy , KE Burdick , H Visweswaraiah , S Abdelmessih , M Lukin , E Yechiam , A Bechara (2007). Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophrenia Research 92, 7484.

MJ Smith , DM Barch , TJ Wolf , D Mamah , JG Csernansky (2008). Elevated rates of substance use disorders in non-psychotic siblings of individuals with schizophrenia. Schizophrenia Research 106, 294299.

BE Snitz , AW Macdonald III, CS Carter (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophrenia Bulletin 32, 179194.

J Stirling , S Lewis , R Hopkins , C White (2005). Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research 75, 135137.

RJ Van Holst , T Schilt (2011). Drug-related decrease in neuropsychological functions of abstinent drug users. Current Drug Abuse Reviews 4, 4256.

M Van 't Wout , A Aleman , RPC Kessels , F Larøi , RS Kahn (2004). Emotional processing in a non-clinical psychosis-prone sample. Schizophrenia Research 68, 271281.

R van Winkel , Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2011). Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis. Archives of General Psychiatry 68, 148157.

CD Verrico , JD Jentsch , RH Roth (2003). Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse 49, 6166.

D Versmissen , I Janssen , I Myin-Germeys , R Mengelers , JA Campo , J van Os , L Krabbendam (2008). Evidence for a relationship between mentalising deficits and paranoia over the psychosis continuum. Schizophrenia Research 99, 103110.

JK Wing , T Babor , T Brugha , J Burke , JE Cooper , R Giel , A Jablenski , D Regier , N Sartorius (1990). SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589593.

J Zubin , B Spring (1977). Vulnerability: a new view of schizophrenia. Journal of Abnormal Psychology 86, 103126.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 8
Total number of PDF views: 40 *
Loading metrics...

Abstract views

Total abstract views: 168 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 25th June 2017. This data will be updated every 24 hours.